Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | CYR61 |
| Upstream (Parents) |
|---|
| (<<) ACTB → CYR61 |
| (<<) ITGB1 → CYR61 |
| (<<) KLF6 → CYR61 |
| (<<) MSN → CYR61 |
| (<<) PPP1R3B → CYR61 |
| (<<) PTK7 → CYR61 |
| (<<) RCAN1 → CYR61 |
| (<<) ROCK2 → CYR61 |
| (<<) STK11 → CYR61 |
| (<<) YWHAH → CYR61 |
| Downstream (Children) |
|---|
| CYR61 → ACTN1 (>>) |
| CYR61 → ADAM9 (>>) |
| CYR61 → CHST12 (>>) |
| CYR61 → CRYAB (>>) |
| CYR61 → CTGF (>>) |
| CYR61 → DUSP1 (>>) |
| CYR61 → DUSP2 (>>) |
| CYR61 → EDN1 (>>) |
| CYR61 → EMG1 (>>) |
| CYR61 → EMP1 (>>) |
| CYR61 → FOS (>>) |
| CYR61 → FOXC2 (>>) |
| CYR61 → GNA12 (>>) |
| CYR61 → HBEGF (>>) |
| CYR61 → IER2 (>>) |
| CYR61 → IL1B (>>) |
| CYR61 → IL6 (>>) |
| CYR61 → ITGA5 (>>) |
| CYR61 → KLF4 (>>) |
| CYR61 → MAL (>>) |
| CYR61 → MAP3K4 (>>) |
| CYR61 → MMP1 (>>) |
| CYR61 → MMP14 (>>) |
| CYR61 → MMP19 (>>) |
| CYR61 → MYL9 (>>) |
| CYR61 → PAK1 (>>) |
| CYR61 → PLAU (>>) |
| CYR61 → PLAUR (>>) |
| CYR61 → PLOD2 (>>) |
| CYR61 → RPL35A (>>) |
| CYR61 → SH3GLB1 (>>) |
| CYR61 → SOD3 (>>) |
| CYR61 → SPRY4 (>>) |
| CYR61 → THBS1 (>>) |
| CYR61 → TIMM13 (>>) |
| CYR61 → TNFRSF10A (>>) |
| CYR61 → TPM1 (>>) |
| CYR61 → TPM2 (>>) |
| CYR61 → ZFP36 (>>) |
